Fadel Alshalabi, the owner and chief executive officer of Crestar Labs LLC, has been charged with aiding and abetting as well as violation of the Anti-Kickback Statute for his role in orchestrating a fraudulent Medicare billing scheme relating to genetic testing in cancer patients. The Justice Department said the tests were approved by telemedicine doctors who did not engage in the treatment of the patients and often did not even speak with the patients for whom they ordered tests. Often, the patients or their treating physicians never received the results of the tests. Read a story from The Daily Herald and a Department of Justice press release.
SMP Resource Center products often contain links to copyrighted material. The SMP Resource Center is providing these links as a convenience and for informational purposes in our efforts to report and educate on Medicare fraud; they do not constitute a guarantee, endorsement, or approval by SMP of any of the information available on the external site. SMP bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links. If you have any questions or concerns about the links provided, please contact the SMP Center at nliebau@smpresource.org.